The Green Organic Dutchman Holdings Ltd. (TGOD) to Exclusively License Fast-Acting Stillwater Foods’ RIPPLE SC

RIPPLE SC is a proprietary, patent-pending suite of low-calorie, fast-acting, water-soluble ingredient products that allows consumers or commercial manufacturers to simply and easily infuse cannabinoids into beverage and food products. RIPPLE SC is formulated to absorb into the bloodstream within fifteen minutes and last for up to four hours, allowing RIPPLE SC-based edibles to offer a uniquely consistent and controlled experience that consumers can trust. Further, while cannabis is by nature fat soluble, edibles utilizing RIPPLE SC’s unique technology require no added fat to carry cannabinoids or sugar to mask cannabinoids’ natural bitterness. As a result, RIPPLE SC enables healthier, better-tasting edibles with no additional sugar, fat, or artificial flavorings.

RIPPLE SC has already proven its value in Colorado, where its consumer variant (marketed as Ripple Dissolvables) is among the fastest-growing products in the edibles category. RIPPLE SC technology also powers other high-end consumer brands such as Stillwater Tea and Whitewater Tea.

TGOD intends to offer Ripple Dissolvables and other Stillwater Brands products and formulations in international markets outside of the USA where regulations allow, as well as in the Canadian market once permitted by the Canadian regulatory regime. Further, TGOD intends to aggressively work on other novel formulations in the beverage, functional foods and dietary supplements areas which will contemplate using RIPPLE SC as the base water-soluble cannabinoid input.

“We believe that soluble cannabinoids and the consumer benefits they enable represent the future of functional foods,” said Justin Singer, CEO of Stillwater Brands. “TGOD’s emphasis on organic, high-quality consumer products makes the Company an ideal partner to carry our vision into the Canadian and international markets.”

“We are excited to have the opportunity to provide a platform to introduce Stillwater’s advanced technologies and formulations worldwide using TGOD’s premium organic ingredients,” said Rob Anderson, Co-Chairman and CEO of TGOD. “This technology will allow TGOD to provide patients and customers around the globe with novel and effective dose-controlled delivery systems that are safer, more standardized, and more discreet than most current cannabinoid delivery systems.”

On Behalf of the Board of Directors,

The Green Organic Dutchman Holdings Ltd.
Robert Anderson
Chief Executive Officer and Co-Chairman

ABOUT THE GREEN ORGANIC DUTCHMAN HOLDINGS LTD.

The Green Organic Dutchman Holdings Ltd. is a research & development company licensed under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”) to cultivate medical cannabis. The Company carries out its principal activities producing cannabis from its facilities in Ancaster, Ont., pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada) and its regulations.

The Company grows high quality, organic cannabis with sustainable, all-natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, safe and consistent product. TGOD has a funded capacity of 116,000 kg and is building 970,000 sq. ft. of cultivation facilities in Ontario and Quebec.

The Company has developed a strategic partnership with Aurora Cannabis Inc. (ACB.TO) whereby Aurora has invested approximately $78.1 million for an approximate 17.5% stake in TGOD. In addition, the Company has raised approximately $290 million dollars and has over 5,000 shareholders.

TGOD’s Common Shares and warrants issued under the indenture dated November 1, 2017 trade on the TSX under the symbol “TGOD” and “TGOD.WT”, respectively.